WhiteOak Capital Pharma and Healthcare Fund Regular-Growth - Returns, Rating & Analysis | Ionic Wealth
WhiteOak Capital Pharma and Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.54% 1D
NAV on
AI Summary
Chart
Overview
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Summary
Ionic AI
Loading...
Fund Overview
Rating
Not Rated
Minimum Investment
₹500
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹603 Cr
Created on
2 Feb 2024
Fund Ranking
#
/ 14 in Sectoral-Pharma
Risk Level
Very High
Very High
Returns
Trailing Return
Rolling Return
6 Month
6.6%
1 Year
15.2%
3 Year (CAGR)
-
All Time (CAGR)
18.8%
Category Return
6 Month
4.9%
1 Year
10.6%
3 Year (CAGR)
23.0%
All Time (CAGR)
-
Asset Allocation
Equity
99.2%
Debt
7.2%
Other
-6.4%
Top 5 Holdings
Top 5 Sectors
Alkyl Amines Chemicals
0.57%
Apollo Hospitals Enterprise
4.02%
Astrazeneca Pharma India
0.95%
Aurobindo Pharma
3.33%
Cipla
0.80%
Fund Information
Expense Ratio
2.57%
Exit Load
No Exit Load
Lock-In Period
No Lock-In
Managed By
Piyush Baranwal
Jan 2024 - Present
Ramesh Mantri
Jan 2024 - Present
Dheeresh Pathak
Jan 2024 - Present
Naitik Shah
April 2024 - Present
Trupti Agrawal
May 2025 - Present
Ashish Agrawal
Jan 2025 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.00
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
0.00
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
0.00
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.